Guochen Shang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guochen Shang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Zhen Ding
Endoscopy Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China
5 shared publications - Chaoqun Han
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
4 shared publications - Rong Lin
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4 shared publications - Jun Liu
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Yu Jin
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Qi He
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Distributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- 26 October 2026
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Open AccessDistributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNA
Background: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)is a well-established, minimally invasive, interventional diagnostic endoscopic technique for the identification of mass lesions; however, its diagnostic accuracy needs further improvement. Most previous studies have focused on the choice of puncture techniques, and rare studies have investigated the effect of distributed sample allocation on the diagnostic accuracy of EUS-FNA. In this study, we aim to investigate the effect of distributed versus nondistributed sample allocation on EUS-FNA diagnostic accuracy. Methods: A total of 248 patients with mass lesions indicated by previous imaging examination were enrolled in this study. The patients were randomly assigned to 2 groups: distributed and nondistributed sample allocation. Clinicopathological features were collected retrospectively and analyzed. Results: Distributed sample allocation can raise the overall EUS-FNA diagnostic accuracy from 88.31% (nondistributed preservation) to 96.34% (distributed preservation). Distributed sample allocation was effective to further increase EUS-FNA diagnostic accuracy ( P =0.0262). Furthermore, for lesions of different locations, the diagnostic accuracy of EUS-FNA of lesions in the mediastinum and lung has improved ( P =0.0128). For lesions of different echogenicity, distributed allocation has effectively improved the diagnostic rate in cystic solid lesions ( P =0.0235). Conclusion: As a rarely considered approach, distributed sample allocation can improve the overall diagnostic accuracy of EUS-FNA.
- Open Access
- 17 October 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 808-814
3D-assisted ERCP enhances cannulation efficiency in malignant biliary obstruction: a prospective two-center study
Background and Aims: Endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary drainage is the standard treatment for malignant biliary obstruction in patients who are not candidates for curative surgery. However, ERCP can be more challenging in patients with pancreatic cancer complicated by obstructive jaundice, often leading to prolonged cannulation times. This study aimed to evaluate the efficacy of three-dimensional (3D) reconstruction-assisted ERCP in treating patients with pancreatic cancer complicated by malignant biliary obstruction. Methods: We performed a two-center prospective study including 72 patients diagnosed with pancreatic cancer complicated by obstructive jaundice. The 36 patients who underwent 3D reconstruction before ERCP constituted the intervention group, while the remaining patients, who received conventional ERCP without 3D assistance, served as the control group. Outcomes evaluated included technical success, procedure duration, X-ray exposure time, clinical success (defined as a ≥50% reduction in serum bilirubin within 5 days), and adverse events. Results: 3D models were successfully constructed for patients in the intervention group and were used for both preoperative planning and intraoperative guidance during ERCP. Compared to conventional ERCP, 3D-assisted ERCP significantly reduced cannulation time (16 min [IQR: 13–30] vs. 13.5 min [IQR: 9–21], P = 0.036) and X-ray exposure time (40.5 s [IQR: 28–69] vs. 34.5 s [IQR: 24–45.5], P = 0.034) for both patients and physicians. No significant differences were observed between the two groups in terms of technical success rates (97.2% vs. 100%, P = 1), clinical success rates (77.8% vs. 83.3%, P = 0.77) or adverse event rates (19.44% vs. 13.89%, P = 0.75). Additionally, no procedure-related mortality occurred. Conclusions: 3D-assisted ERCP significantly reduces the X-ray exposure time and shortens cannulation time for both patients and physicians, making it a valuable tool for treating malignant biliary obstruction. Highlights: This prospective two-center study demonstrates that 3D reconstruction-assisted ERCP can significantly reduce X-ray exposure time and overall procedure duration, thereby enhancing safety and efficiency in the management of malignant biliary obstruction.
- 17 October 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 808-814
Open Access3D-assisted ERCP enhances cannulation efficiency in malignant biliary obstruction: a prospective two-center study
Background and Aims: Endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary drainage is the standard treatment for malignant biliary obstruction in patients who are not candidates for curative surgery. However, ERCP can be more challenging in patients with pancreatic cancer complicated by obstructive jaundice, often leading to prolonged cannulation times. This study aimed to evaluate the efficacy of three-dimensional (3D) reconstruction-assisted ERCP in treating patients with pancreatic cancer complicated by malignant biliary obstruction. Methods: We performed a two-center prospective study including 72 patients diagnosed with pancreatic cancer complicated by obstructive jaundice. The 36 patients who underwent 3D reconstruction before ERCP constituted the intervention group, while the remaining patients, who received conventional ERCP without 3D assistance, served as the control group. Outcomes evaluated included technical success, procedure duration, X-ray exposure time, clinical success (defined as a ≥50% reduction in serum bilirubin within 5 days), and adverse events. Results: 3D models were successfully constructed for patients in the intervention group and were used for both preoperative planning and intraoperative guidance during ERCP. Compared to conventional ERCP, 3D-assisted ERCP significantly reduced cannulation time (16 min [IQR: 13–30] vs. 13.5 min [IQR: 9–21], P = 0.036) and X-ray exposure time (40.5 s [IQR: 28–69] vs. 34.5 s [IQR: 24–45.5], P = 0.034) for both patients and physicians. No significant differences were observed between the two groups in terms of technical success rates (97.2% vs. 100%, P = 1), clinical success rates (77.8% vs. 83.3%, P = 0.77) or adverse event rates (19.44% vs. 13.89%, P = 0.75). Additionally, no procedure-related mortality occurred. Conclusions: 3D-assisted ERCP significantly reduces the X-ray exposure time and shortens cannulation time for both patients and physicians, making it a valuable tool for treating malignant biliary obstruction. Highlights: This prospective two-center study demonstrates that 3D reconstruction-assisted ERCP can significantly reduce X-ray exposure time and overall procedure duration, thereby enhancing safety and efficiency in the management of malignant biliary obstruction.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 14 (1) , 37-39
A rare complication of EUS-guided biliary drainage (with video)
- 1 January 2025
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 14 (1) , 37-39
Open AccessA rare complication of EUS-guided biliary drainage (with video)
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 293-299
Open AccessThe comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS
Background and Objectives: There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC. Methods: A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed. Results: Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age (P = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia (P < 0.001) and weight loss (P < 0.001) during the disease progression. Significant increases in the tumor size (P < 0.001), thickness of the affected gastric wall (P < 0.001), and depth of tumor invasion (P < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels (P < 0.001), nerves (P < 0.001), lymph nodes (P < 0.001), and peritoneal metastasis (P < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients. Conclusions: The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 287-292
Impact of biliary-pancreatic double stents on EUS-guided tissue acquisition among patients with solid pancreatic lesions: A multicenter study
Background and Objective: Although the impact of biliary stents on the accuracy of EUS-guided tissue acquisition (EUS-TA) is still controversial, the influence of biliary-pancreatic double stents on EUS-TA is even more inconclusive. The aim of the study was to determine whether the diagnostic yield of EUS-FNA in the diagnosis of solid pancreatic lesions will be affected after placement of biliary-pancreatic double stents. Methods: A multicenter retrospective study including patients who underwent EUS-FNA with biliary duct obstruction was performed. Patients were divided into 2 groups according to whether there were biliary-pancreatic double stents before EUS-FNA. The patients' EUS-FNA report, histopathological results, and clinical case data were reviewed and compared. Results: Ninety-two patients were included, 42 with biliary-pancreatic double stents and 50 without any stents. The puncture time taken by EUS-FNA was significantly longer in the stent group than the no-stent group (19 vs. 15 min, P < 0.001). No significant differences were observed in accuracy (90.5% vs. 94%), sensitivity (89.5% vs. 93.6%), specificity (100% vs. 100%), NPV (50% vs. 50%), PPV (100% vs. 100%), respectively, in both groups. Patients with larger lesions (OR = 1.600, 95% CI: 1.124–2.277) and those who required more passes had a higher diagnostic yield (OR = 9.376, 95% CI: 1.356–64.819) by multivariate analysis. Conclusions: ERCP before EUS-FNA is feasible for the treatment of solid pancreatic lesions causing obstructive jaundice. It will not have a negative impact on the diagnostic accuracy and surgical complications, but the EUS-FNA operation time will be prolonged.
- 1 September 2024
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 13 (5) , 287-292
Open AccessImpact of biliary-pancreatic double stents on EUS-guided tissue acquisition among patients with solid pancreatic lesions: A multicenter study
Background and Objective: Although the impact of biliary stents on the accuracy of EUS-guided tissue acquisition (EUS-TA) is still controversial, the influence of biliary-pancreatic double stents on EUS-TA is even more inconclusive. The aim of the study was to determine whether the diagnostic yield of EUS-FNA in the diagnosis of solid pancreatic lesions will be affected after placement of biliary-pancreatic double stents. Methods: A multicenter retrospective study including patients who underwent EUS-FNA with biliary duct obstruction was performed. Patients were divided into 2 groups according to whether there were biliary-pancreatic double stents before EUS-FNA. The patients' EUS-FNA report, histopathological results, and clinical case data were reviewed and compared. Results: Ninety-two patients were included, 42 with biliary-pancreatic double stents and 50 without any stents. The puncture time taken by EUS-FNA was significantly longer in the stent group than the no-stent group (19 vs. 15 min, P < 0.001). No significant differences were observed in accuracy (90.5% vs. 94%), sensitivity (89.5% vs. 93.6%), specificity (100% vs. 100%), NPV (50% vs. 50%), PPV (100% vs. 100%), respectively, in both groups. Patients with larger lesions (OR = 1.600, 95% CI: 1.124–2.277) and those who required more passes had a higher diagnostic yield (OR = 9.376, 95% CI: 1.356–64.819) by multivariate analysis. Conclusions: ERCP before EUS-FNA is feasible for the treatment of solid pancreatic lesions causing obstructive jaundice. It will not have a negative impact on the diagnostic accuracy and surgical complications, but the EUS-FNA operation time will be prolonged.
- Open Access
- 11 October 2022
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 118 (5) , 802-811
Reduced Adenoma Miss Rate With 9-Minute vs 6-Minute Withdrawal Times for Screening Colonoscopy: A Multicenter Randomized Tandem Trial
INTRODUCTION: Although the 9-minute mean withdrawal time (m-WT) is often reported to be associated with the optimal adenoma detection rate (ADR), no randomized trials of screening colonoscopy have confirmed the impact of a 9-minute m-WT on adenoma miss rate (AMR) and ADR. METHODS: A multicenter tandem trial was conducted in 11 centers. Seven hundred thirty-three asymptomatic participants were randomized to receive segmental tandem screening colonoscopy with a 9-minute withdrawal, followed by a 6-minute withdrawal (9-minute-first group, 9MF, n = 366) or vice versa (6-minute-first group, 6MF, n = 367). The primary outcome was the lesion-level AMR. RESULTS: The intention-to-treat analysis revealed that 9MF significantly reduced the lesion-level (14.5% vs 36.6%, P < 0.001) and participant-level AMR (10.9% vs 25.9%, P < 0.001), advanced adenoma miss rate (AAMR, 5.3% vs 46.9%, P = 0.002), multiple adenomas miss rate (20.7% vs 56.5%, P = 0.01), and high-risk adenomas miss rate (14.6% vs 39.5%, P = 0.01) of 6MF without compromising detection efficiency ( P = 0.79). In addition, a lower false-negative rate for adenomas ( P = 0.002) and high-risk adenomas ( P < 0.05), and a lower rate of shortening surveillance schedule ( P < 0.001) were also found in 9MF, accompanying with an improved ADR in the 9-minute vs 6-minute m-WT (42.3% vs 33.5%, P = 0.02). The independent inverse association between m-WT and AMR remained significant even after adjusting ADR, and meanwhile, 9-minute m-WT was identified as an independent protector for AMR and AAMR. DISCUSSION: In addition to increasing ADR, 9-minute m-WT also significantly reduces the AMR and AAMR of screening colonoscopy without compromising detection efficiency.
- 11 October 2022
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 118 (5) , 802-811
Open AccessReduced Adenoma Miss Rate With 9-Minute vs 6-Minute Withdrawal Times for Screening Colonoscopy: A Multicenter Randomized Tandem Trial
INTRODUCTION: Although the 9-minute mean withdrawal time (m-WT) is often reported to be associated with the optimal adenoma detection rate (ADR), no randomized trials of screening colonoscopy have confirmed the impact of a 9-minute m-WT on adenoma miss rate (AMR) and ADR. METHODS: A multicenter tandem trial was conducted in 11 centers. Seven hundred thirty-three asymptomatic participants were randomized to receive segmental tandem screening colonoscopy with a 9-minute withdrawal, followed by a 6-minute withdrawal (9-minute-first group, 9MF, n = 366) or vice versa (6-minute-first group, 6MF, n = 367). The primary outcome was the lesion-level AMR. RESULTS: The intention-to-treat analysis revealed that 9MF significantly reduced the lesion-level (14.5% vs 36.6%, P < 0.001) and participant-level AMR (10.9% vs 25.9%, P < 0.001), advanced adenoma miss rate (AAMR, 5.3% vs 46.9%, P = 0.002), multiple adenomas miss rate (20.7% vs 56.5%, P = 0.01), and high-risk adenomas miss rate (14.6% vs 39.5%, P = 0.01) of 6MF without compromising detection efficiency ( P = 0.79). In addition, a lower false-negative rate for adenomas ( P = 0.002) and high-risk adenomas ( P < 0.05), and a lower rate of shortening surveillance schedule ( P < 0.001) were also found in 9MF, accompanying with an improved ADR in the 9-minute vs 6-minute m-WT (42.3% vs 33.5%, P = 0.02). The independent inverse association between m-WT and AMR remained significant even after adjusting ADR, and meanwhile, 9-minute m-WT was identified as an independent protector for AMR and AAMR. DISCUSSION: In addition to increasing ADR, 9-minute m-WT also significantly reduces the AMR and AAMR of screening colonoscopy without compromising detection efficiency.